Can mucopolysaccharidosis type I disease severity be predicted based on a patient’s genotype? A comprehensive review of the literature

This publication has 34 references indexed in Scilit:

• Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations
  Human Genetics, 2001
• Identification and characterization of ‐3c–g acceptor splice site mutation in human α‐ l‐iduronidase associated with mucopolysaccharidosis type IH/S
  Clinical Genetics, 2000
• Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres
  Archives of Disease in Childhood, 1997
• Molecular genetics of muccpolysaccharidosis type I: Diagnostic, clinical, and biological implications
  Human Mutation, 1995
• Four novel mutations underlying mild or intermediate forms of α-L-iduronidase deficiency (MPS IS and MPS IH/S)
  Human Mutation, 1995
• A mutant stop codon (TAG) in the IDUA gene is used as an acceptor splice site in a patient with Hurler syndrome (MPS IH)
  Human Mutation, 1994
• Multiple polymorphisms within the α-L-iduronidase gene (IDUA): implications for a role in modification of MPS-I disease phenotype
  Human Molecular Genetics, 1993
• Two novel mutations causing mucopolysaccharidosis type I detected by single strand conformational analysis of the α-L-iduronidase gene
  Human Molecular Genetics, 1993
• A deletion/insertion mutation in theIDUA gene in a Libyan Jewish patient with Hurler syndrome (mucopolysaeeharidosis IH)
  Human Mutation, 1993
• Mutation in Scheie syndrome (MPS IS): A G→A transition creates new splice site in intron 5 of one IDUA allele
  Human Mutation, 1993